Viravecs Labs

  • Bangalore, India
  • HealthcareBiotechnology, Research

Viravecs Labs is a Gene Therapy Company battling rare genetic disorders and oncology using technologies like Genome Editing & Viral Vectors.

Founded:
2014
Stage:
Proof of Concept
Market:
B2B

Startup Video

Featured

Image

CNBC Young Turns | CNBC

We were covered as a part of the Biotech special version of CNBC Young Turks.

Sep 30, 2017

Image

Hot Startups: Pioneers in Genome Editing | Biospectrum

Covered by Biospectrum in their "Hot Startups" sections.

Sep 06, 2016


Jobs


Team Summary

Wait

Team

Founding Team

Rohan H. Kamat


Founder
WORK

ViraVecs Labs LLP. (2014 - present)
Co Founder

Aten Porus Lifesciences (2015 - 2015)
Rohan

TMC-ACTREC. (2004 - 2010)
Graduate student

EDUCATION

Ruia
B.Sc. • 1999 - 2002

University of Mumbai
Master of Science (MSc) • 1999 - 2002

S.E.S. High School, Thane, Maharashtra, India.
Higher secondary school • 1988 - 1997

Current - Chief Scientific Officer and Co-Founder @Viravecs Labs; Research Officer@ Institute of Molecular Bioscience, The University of Queensland

Product/Service Summary

Viravecs Labs is a drug discovery company focusing on rare genetic diseases and oncology. We exclusively work in the gene therapy space wherein we not only develop cutting edge tools for gene therapy, but also develop therapeutic models.
Viravecs Labs has the complete gamut of skills required for genetic tinkering of the mammalian systems. We can mimic a disease in cells and small animals like mice and even show disease reversal by genetic intervention.
What we bring to the table is a number of novel technology platforms that will progress the field of gene therapy. Our focus on rare diseases & oncology assisted with our assets that deal with the root cause of the disease, makes us a unique player in the healthcare industry.

Product/Service Descriptions